Jason Dorr
InvestorAssociate at HEALTHCARE ROYALTY PARTNERS
About
Jason Dorr is an Associate at HCRx, where he primarily supports research efforts and contributes to business development and transaction work including financial analysis, transaction structuring, and due diligence. He previously worked as a biotechnology equity research associate at Oppenheimer & Co., covering SMID-cap equities in endocrinology, immunology, and orphan diseases, and as a consultant at L.E.K. Consulting advising biotechnology companies. He earned a PharmD from Rutgers University.
Invests in
Biotech
Colleagues at HEALTHCARE ROYALTY PARTNERS
Aaron B. Simon
Associate at HEALTHCARE ROYALTY PARTNERS
Amy J. Zacharias
Senior Vice President and Controller at HEALTHCARE ROYALTY PARTNERS
Andrew Logerfo
Vice President at HEALTHCARE ROYALTY PARTNERS
Carlos M. Almodóvar
Chief Business Officer at HEALTHCARE ROYALTY PARTNERS
Christopher A. White
President and Chief Financial Officer at HEALTHCARE ROYALTY PARTNERS
Clarke B. Futch
Chairman and Chief Executive Officer at HEALTHCARE ROYALTY PARTNERS
David Oron
Analyst at HEALTHCARE ROYALTY PARTNERS
Eric Yoo
Vice President, PharmD at HEALTHCARE ROYALTY PARTNERS
Frequently asked questions
- Who is Jason Dorr?
- Jason Dorr is an Associate at HCRx, where he primarily supports research efforts and contributes to business development and transaction work including financial analysis, transaction structuring, and due diligence. He previously worked as a biotechnology equity research associate at Oppenheimer & Co., covering SMID-cap equities in endocrinology, immunology, and orphan diseases, and as a consultant at L.E.K. Consulting advising biotechnology companies. He earned a PharmD from Rutgers University.
- Where does Jason Dorr work?
- Jason Dorr is Associate at HEALTHCARE ROYALTY PARTNERS.
- What does Jason Dorr invest in?
- Jason Dorr invests in Biotech.